Home » Topics » Regulatory » Patents

Patents
RSS

PTK inhibitors for bone disorders from Novartis

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Roussel Uclaf discloses integrin antagonists for bone disorders

Nov. 26, 1997

Takeda develops potassium channel openers for cardiovascular indications

Nov. 26, 1997

New agents for heart disease prepared by Dainippon Ink & Chemicals

Nov. 26, 1997

DNA-intercalating agents reported by Mitsui Toatsu in patent literature

Nov. 25, 1997

Sankyo discloses inositol 1,4,5-triphosphate inhibitors

Nov. 25, 1997

Dual CysLT1/H1 receptor antagonists described in patent literature

Nov. 25, 1997

Novel beta-agonists for obesity and diabetes described by SmithKline Beecham

Nov. 25, 1997

SKB describes novel 5-HT1B antagonists

Nov. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026